Search results
Results From The WOW.Com Content Network
Mueller–Weiss syndrome, also known as Mueller–Weiss disease, is a rare [2] idiopathic degenerative disease of the adult navicular bone characterized by progressive collapse and fragmentation, leading to mid- and hindfoot pain and deformity. [3] [1] It is most commonly seen in females, ages 40–60. [4]
The use of intramuscular glycosaminoglycans has been shown to decrease pain in horses with navicular disease, but this effect wanes after discontinuation of therapy. [23] Oral glycosaminoglycans may have a similar effect. [24] Bisphosphonates can be useful in cases where bone remodeling is causing pain. [25]
Navicular disease or navicular syndrome: a catch-all phrase used to describe pain in the palmar hoof which was originally attributed to damage to the navicular bone. MRI has since shown that navicular syndrome may be caused by damage to any of the structures within the hoof, including the navicular bone, the navicular bursa, the coffin joint ...
The disease typically affects boys, but it can also affect girls. It was first described in 1908 by Alban Köhler (1874–1947), a German radiologist. [2] [3] Dr. A. Köhler noted that children with foot pain displayed characteristics, within their x-rays, of irregularity in growth and development of the tarsal navicular bone in the foot ...
"I can't live in a flood zone where you are constantly having to move out for six or seven months." ... accepting ‘cash only’ deals to walk away forever after 2 major hurricanes in 2 weeks.
The two brothers have Duchenne muscular dystrophy — a rare, inherited muscle-wasting disorder that has no cure. "Caleb stopped walking in December of '23, so a little over a year ago.
Dick Vitale said he's cancer-free after his fourth bout with the disease in just over three years. The 85-year-old ESPN college basketball analyst announced Thursday on social media that he got ...
In veterinary medicine, tiludronic acid is used to treat navicular disease and bone spavin in horses. Its tradenames are Tildren and Equidronate. It is approved for treatment of navicular disease and distal, tarsal osteoarthritis in Europe, [1] and was approved for treatment of navicular disease in the United States in 2014.